鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/02/21 | 4,040 | 4,085 | 3,995 | 4,030 | -10 | -0.2% | 31,600 |
| 2024/02/20 | 4,040 | 4,070 | 4,025 | 4,040 | +10 | +0.2% | 20,900 |
| 2024/02/19 | 4,025 | 4,040 | 3,955 | 4,030 | -40 | -1% | 37,400 |
| 2024/02/16 | 3,965 | 4,090 | 3,945 | 4,070 | +170 | +4.4% | 76,100 |
| 2024/02/15 | 3,895 | 3,900 | 3,850 | 3,900 | +5 | +0.1% | 34,300 |
| 2024/02/14 | 3,915 | 3,950 | 3,855 | 3,895 | -80 | -2% | 82,200 |
| 2024/02/13 | 3,820 | 3,980 | 3,780 | 3,975 | +360 | +10% | 134,900 |
| 2024/02/09 | 3,660 | 3,675 | 3,615 | 3,615 | -45 | -1.2% | 27,400 |
| 2024/02/08 | 3,660 | 3,690 | 3,620 | 3,660 | -15 | -0.4% | 28,800 |
| 2024/02/07 | 3,670 | 3,710 | 3,655 | 3,675 | +5 | +0.1% | 17,900 |
| 2024/02/06 | 3,700 | 3,725 | 3,670 | 3,670 | -30 | -0.8% | 30,200 |
| 2024/02/05 | 3,730 | 3,745 | 3,680 | 3,700 | -30 | -0.8% | 31,600 |
| 2024/02/02 | 3,750 | 3,755 | 3,695 | 3,730 | -20 | -0.5% | 29,600 |
| 2024/02/01 | 3,720 | 3,770 | 3,715 | 3,750 | -15 | -0.4% | 25,300 |
| 2024/01/31 | 3,700 | 3,765 | 3,685 | 3,765 | +40 | +1.1% | 35,100 |
| 2024/01/30 | 3,820 | 3,830 | 3,725 | 3,725 | -55 | -1.5% | 21,700 |
| 2024/01/29 | 3,800 | 3,820 | 3,775 | 3,780 | ±0 | ±0% | 21,000 |
| 2024/01/26 | 3,805 | 3,805 | 3,760 | 3,780 | -20 | -0.5% | 18,600 |
| 2024/01/25 | 3,760 | 3,800 | 3,760 | 3,800 | +40 | +1.1% | 32,900 |
| 2024/01/24 | 3,810 | 3,835 | 3,750 | 3,760 | -40 | -1.1% | 17,000 |
| 2024/01/23 | 3,750 | 3,825 | 3,750 | 3,800 | +55 | +1.5% | 29,600 |
| 2024/01/22 | 3,775 | 3,780 | 3,740 | 3,745 | -5 | -0.1% | 14,400 |
| 2024/01/19 | 3,690 | 3,750 | 3,690 | 3,750 | +65 | +1.8% | 17,100 |
| 2024/01/18 | 3,685 | 3,715 | 3,670 | 3,685 | ±0 | ±0% | 12,100 |
| 2024/01/17 | 3,705 | 3,750 | 3,685 | 3,685 | -20 | -0.5% | 13,000 |
| 2024/01/16 | 3,740 | 3,755 | 3,705 | 3,705 | -65 | -1.7% | 13,200 |
| 2024/01/15 | 3,725 | 3,785 | 3,700 | 3,770 | +60 | +1.6% | 17,700 |
| 2024/01/12 | 3,675 | 3,750 | 3,670 | 3,710 | +50 | +1.4% | 33,700 |
| 2024/01/11 | 3,675 | 3,700 | 3,650 | 3,660 | -25 | -0.7% | 47,500 |
| 2024/01/10 | 3,685 | 3,710 | 3,660 | 3,685 | +10 | +0.3% | 26,400 |
| 2024/01/09 | 3,680 | 3,695 | 3,655 | 3,675 | +25 | +0.7% | 30,100 |
| 2024/01/05 | 3,645 | 3,685 | 3,645 | 3,650 | +10 | +0.3% | 34,400 |
| 2024/01/04 | 3,565 | 3,640 | 3,540 | 3,640 | +85 | +2.4% | 28,200 |
| 2023/12/29 | 3,520 | 3,555 | 3,520 | 3,555 | +35 | +1% | 20,200 |
| 2023/12/28 | 3,535 | 3,535 | 3,505 | 3,520 | -80 | -2.2% | 20,500 |
| 2023/12/27 | 3,550 | 3,610 | 3,550 | 3,600 | +30 | +0.8% | 34,700 |
| 2023/12/26 | 3,585 | 3,595 | 3,565 | 3,570 | -15 | -0.4% | 19,400 |
| 2023/12/25 | 3,650 | 3,650 | 3,585 | 3,585 | -10 | -0.3% | 21,400 |
| 2023/12/22 | 3,560 | 3,625 | 3,545 | 3,595 | +65 | +1.8% | 32,000 |
| 2023/12/21 | 3,510 | 3,550 | 3,490 | 3,530 | -10 | -0.3% | 23,400 |
| 2023/12/20 | 3,535 | 3,575 | 3,535 | 3,540 | +15 | +0.4% | 27,600 |
| 2023/12/19 | 3,485 | 3,530 | 3,485 | 3,525 | +65 | +1.9% | 36,500 |
| 2023/12/18 | 3,460 | 3,475 | 3,415 | 3,460 | +25 | +0.7% | 29,700 |
| 2023/12/15 | 3,505 | 3,510 | 3,420 | 3,435 | -85 | -2.4% | 53,200 |
| 2023/12/14 | 3,565 | 3,590 | 3,495 | 3,520 | -60 | -1.7% | 44,600 |
| 2023/12/13 | 3,565 | 3,590 | 3,525 | 3,580 | +20 | +0.6% | 33,200 |
| 2023/12/12 | 3,630 | 3,655 | 3,555 | 3,560 | -70 | -1.9% | 32,800 |
| 2023/12/11 | 3,615 | 3,640 | 3,605 | 3,630 | +25 | +0.7% | 30,700 |
| 2023/12/08 | 3,670 | 3,670 | 3,585 | 3,605 | -70 | -1.9% | 42,000 |
| 2023/12/07 | 3,710 | 3,710 | 3,660 | 3,675 | -45 | -1.2% | 29,600 |
51～
100
件表示中 / 3450件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 401,000円 | +7.3% | +16.8% | 2.99% | 23.99倍 | 0.94倍 |
|
ＪＴ傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗ＨＩＶ薬の販売権喪失が直撃 |
| 持田薬 | 322,500円 | -1.2% | -37.3% | 2.48% | 25.98倍 | 0.90倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 183,100円 | +2.6% | +11.5% | 2.84% | 21.46倍 | 0.83倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ゼリア新薬 | 211,300円 | +6.8% | +18.7% | 2.08% | 13.31倍 | 1.23倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ＪＣＲファーマ | 80,100円 | +32.2% | +84.6% | 2.50% | 13.70倍 | 1.78倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
